MRNA
MRNA

Moderna

Market cap $16.0B

Moderna (MRNA) is a publicly traded company. As of November 8, 2026, Invest's signal rates MRNA a Hold. You can practice trading MRNA risk-free with €1,000,000 in virtual cash.

Key stats

As of November 8, 2026

Market Cap

$16.0B

Volume

—

52-wk High

—

52-wk Low

—

Day High

—

Day Low

—

MRNA overview

AI overview

How to practice trading MRNA

  1. 1

    Use the MRNA buy panel above

    Set a quantity and hit Buy at the real market price — right here, nothing to download.

  2. 2

    Trade with €1,000,000 virtual cash

    You get a million in virtual money instantly to invest, risk-free.

  3. 3

    Create a free account to save it

    Sign up in seconds to keep your portfolio and track its performance.

  4. 4

    Track and compete

    Watch your portfolio grow and climb the global leaderboard — or start a private league.

  5. 5

    Prefer mobile? Get the iOS app

    Invest is also free on the App Store, synced with your web account.

Top MRNA traders on Invest

Full leaderboard
🥇Emma R.+155.0%
🥈Aoife B.+140.0%
🥉Zoe T.+130.0%
#4amara_k+119.0%
#5Julia M.+106.0%

Frequently asked questions

Is MRNA a good stock to buy right now?

As of November 8, 2026, Invest's signal rates MRNA a Hold, based on its price trend, valuation, and fundamentals. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading MRNA risk-free first.

What is Moderna's (MRNA) market cap?

Moderna has a market capitalization of approximately $16.0B.

How has MRNA stock performed?

MRNA is actively traded. Its 52-week range runs roughly from — to —. Past performance doesn't predict future results.

How can I practice trading MRNA for free?

On Invest you get €1,000,000 in virtual cash and can buy MRNA at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.

More stocks to practice

Compare MRNA with peers

Invest — Stock Market SimulatorNot financial advice.